Back to SEI Investments Co. SEI Investments Co.

AXSMAXSM

Showing 8 of 30 quarters

Position history for SEI Investments Co.SEI Investments Co.'s holdings in Axsome Therapeutics, Inc.

Yes. SEI Investments holds 76,462 shares of AXSM (Axsome Therapeutics), worth $18.7M, as of its Q2 2026 13F filing. It increased the position by 6,398 shares (+9.1%) from Q1 2026. SEI Investments has held AXSM since Q1 2019, across 30 quarterly 13F filings.

Current Value

$18.7M

Current Shares

76,462

Total Value Change

+$14.4M

Total Shares Change

+28,101

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
76,462
+9.1%
$18.7M0.0%$244.77
31
2026-Q1
Increased
70,064
+47.2%
$11.8M0.0%$169.02
38
2025-Q4
Decreased
47,600
-1.1%
$8.7M0.0%$182.64
0
2025-Q3
Increased
48,127
+9.5%
$5.8M0.0%$121.45
30
2025-Q2
Increased
43,949
+23.0%
$4.6M0.0%$104.39
33
2025-Q1
Decreased
35,729
-25.9%
$4.2M0.0%$116.63
0
2024-Q4
Decreased
48,230
-0.3%
$4.1M0.0%$84.61
0
2024-Q3
Increased
48,361
+19.1%
$4.3M0.0%$89.87
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used